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Background: Mortality prediction models are applied in the intensive care unit (ICU) 
to stratify patients into different risk categories and to facilitate benchmarking. To 
ensure that the correct prediction models are applied for these purposes, the best 
performing models must be identified. As a first step, we aimed to establish a system-
atic review of mortality prediction models in critically ill patients.
Methods: Mortality prediction models were searched in four databases using the fol-
lowing criteria: developed for use in adult ICU patients in high-income countries, with 
mortality as primary or secondary outcome. Characteristics and performance measures 
of the models were summarized. Performance was presented in terms of discrimination, 
calibration and overall performance measures presented in the original publication.
Results: In total, 43 mortality prediction models were included in the final analy-
sis. In all, 15 models were only internally validated (35%), 13 externally (30%) and 
10 (23%) were both internally and externally validated by the original research-
ers. Discrimination was assessed in 42 models (98%). Commonly used calibration 
measures were the Hosmer-Lemeshow test (60%) and the calibration plot (28%). 
     |  425KEUNING Et al.
1  | INTRODUC TION
Outcome prediction models, severity scales and risk scores are prog-
nostic tools to estimate the probability for a pre-specified outcome.1 
These prognostic tools use variables (eg about the severity of illness) to 
predict outcome, often mortality, in a specific patient population such 
as the critically ill. In the intensive care unit (ICU), mortality prediction 
models may be applied to stratify patients in different risk categories 
and to facilitate benchmarking using standardized mortality rates. An 
accurate mortality prediction model provides a stratification of the risk 
of an outcome at a population level. These models generally provide a 
numerical estimate of that risk based on estimates from previous pop-
ulations.2 Per definition, all mortality prediction models are best suited 
for use at a population level and not for individual prognostication, as 
uncertainty for individual patients remains high.3,4
Several models are widely known and broadly applied such as 
the Acute Physiology and Chronic Health Evaluation (APACHE) I-IV, 
the Mortality Prediction Model (MPM) and the Simplified Acute 
Physiology Score (SAPS) I-III,5 whereas others like the Intensive 
Care National Audit & Research Centre (ICNARC) are used solely 
in one country.6 Previous literature has only reviewed commonly 
used models, models with different outcome than mortality or dis-
ease- or organ-specific prognostic models.3-5,7,8 To the best of our 
knowledge, no study has systematically assessed which mortality 
prediction models have been developed and validated for broad co-
horts of adult critically ill patients.
1.1 | Rationale and objective
The objective of this study was to provide an overview of available 
mortality prediction models in adult critically ill patients as a step-
up towards future head-to-head comparison of model performance 
through systematic external validation.
2  | METHODS
2.1 | Protocol and registration
This scoping review was performed following our protocol (Appendix 
S1) and was reported in accordance with the PRISMA-ScR checklist.9 
Notably, we aimed to publish the protocol on PROSPERO, but dur-
ing the process it showed that PROSPERO currently does not ac-
cept registrations for scoping reviews, literature reviews or mapping 
reviews.
2.2 | Search strategy
We conducted a systematic search of MEDLINE, EMBASE, Web 
of Science and The Cochrane Central Register of Controlled Trials 
(CENTRAL) to identify relevant ICU mortality prediction models 
(Appendix S1). Mortality was chosen as the outcome of interest, 
as prediction models were originally developed to identify patients 
with high mortality risk. For all databases, except the CENTRAL da-
tabase, the search period encompassed a period starting from the 
1st January 2008 to the 21st April 2019. We used snowballing, that 
is, searching references and related articles, to identify additional 
prediction models that were published before 2008.
One author ran the search, after which the screening of records 
and data extraction were performed in duplicate. All records were 
screened based on title and/or abstract. Papers clearly irrelevant to 
the purpose were excluded. The remaining articles were screened 
for eligibility. Consulting a third opinion solved disagreements. More 
detailed information is presented in the protocol (Appendix S1).
2.3 | Eligibility criteria
To be considered eligible, mortality prediction models had to meet the 
following criteria: (a) originally developed specifically for use in adult 
critically ill patients as defined by the included studies, (b) representing 
Calibration was not assessed in 11 models (26%). Overall performance was assessed 
in the Brier score (19%) and the Nagelkerke's R2 (4.7%).
Conclusions: Mortality prediction models have varying methodology, and valida-
tion and performance of individual models differ. External validation by the original 
researchers is often lacking and head-to-head comparisons are urgently needed to 
identify the best performing mortality prediction models for guiding clinical care and 
research in different settings and populations.
Editorial Comment
In this review, mortality prediction models in intensive care 
have been identified. Characteristics and performance of 
43 individual models are summarized according to docu-
mentation in the original publications so that validation 
and predictive performances can be compared.
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broad groups of ICU patients (with large diversity of admission diagno-
ses, eg non-diabetic patients, medical admissions, surgical admissions, 
etc), (c) availability of the original article in English and (d) mortality at 
any time as (primary or secondary) outcome of interest.
Prediction models were excluded (a) when developed for low- or 
middle-income countries, as characteristics of ICU patients in these 
countries often substantially differ from those in high-income coun-
tries and, epidemiological data from low-income countries have been 
frequently unavailable,10,11 (b) when developed as a digital model or 
derived from a machine-learning algorithm, since code and data avail-
ability are not requirements in all journals. Since our utmost goal is 
to make a head-to-head comparison of available mortality prediction 
models using an independent external validation cohort, the code or 
data necessary to retrieve the underlying prediction model formula are 
required to reproduce the prediction models. (c) When the develop-
ment of multiple customized prediction models was described in one 
article, but no final model was proposed, the prediction models were 
excluded. Finally, (d) we excluded prediction models specifically devel-
oped for subgroups of intensive care patients such as those with sep-
sis, trauma, cardiac and neurological patients. Studies not specifying 
inclusion of these subgroups within a wider, general ICU population 
were considered to be eligible. Prediction models developed in a med-
ical or surgical ICU were included.
2.4 | Data extraction
If multiple mortality outcomes (eg at different time points) were 
used, we used the primary outcome in the original publication (or the 
first mortality outcome if the primary outcome was not mortality) to 
describe the performance of the prediction model.
Details on the development process of the mortality prediction 
models included were shown, as well as the number of variables in-
cluded in the prediction models, mortality rate in each development 
setting and method of handling of missing data. To give an overview 
of the performance of all mortality prediction models, for example, 
values from discrimination, calibration and overall performances 
measures12 for mortality were presented for development and in-
ternal or external validation cohorts in the original publication (if 
available).
The discrimination measure presented was the C-statistic (area 
under the receiver operating characteristic curve [AUROC]), calibra-
tion measures presented were goodness-of-fit tests like the Hosmer-
Lemeshow (HL) test, calibration plot and calibration slope, and the 
overall performance measures presented were the Nagelkerke's R2 
and the Brier score.12
Preferable values from external validation were presented if 
both internal and external validation values were present in the 
F I G U R E  1   Flow diagram of the search [Colour figure can be viewed at wileyonlinelibrary.com]
     |  427KEUNING Et al.
original publication. If not available, values of internal validation 
cohorts were presented. External validation was defined as using a 
separate individual dataset for validation of the mortality prediction 
model (ie no split sampling of a dataset also used for the develop-
ment of the model).
Citations of original publications were screened for internal and/
or external validation articles and shown as being present (+) or ab-
sent (−). A list of variables sought for in the identified articles can be 
found in Appendix S1.
3  | RESULTS
The selection of sources of evidence can be found in the flowchart 
(Figure 1). Articles evidently developed for specific groups of pa-
tients (ie sepsis, trauma, cardiac, neurological patients) were ex-
cluded based on the title and/or abstract. Evaluating 99 full-text 
articles for eligibility resulted in exclusion of another 39 articles, 
leaving 60 articles that were screened for original publications. 
Eventually, 43 relevant mortality prediction models reported in 38 
publications were extracted and included in the final analysis.
3.1 | Characteristics of the included mortality 
prediction models
Characteristics of the mortality prediction models and underlying 
derivation cohorts are presented in Table 1. In all, 19 mortality pre-
diction models (44%) were developed using prospectively collected 
data specifically gathered for the development of the prediction 
model,6,13-27 whereas 24 (56%) were developed using either retro-
spective data28-44 or prospective data previously collected for other 
purposes.45-49 The start of data collection for the development co-
horts spanned 36 years (1979-2015), and the duration of the cohort 
studies varying from 2 months up to 10 years for each cohort. Two 
mortality prediction models (4.7%) did not report the timespan dur-
ing which their development cohort was assembled.22,33 In all, 31 
mortality prediction models (74%) were developed in a single coun-
try,14,18-27,29,31,33-45,47,49 six (14%) in neighbouring countries (two or 
more)6,13,28,30,32,46 and five (12%) were developed in multiple coun-
tries worldwide.15-17,48 The number of patients included in the de-
velopment databases ranged from 232 to 731 611 patients with a 
median of 4,895 (IQR 528-35 878). The minimum age at which pa-
tients were included was 15 years (2.3%).35 In all, 11 mortality pre-
diction models (26%) did not specify age.6,13,23,25,29,31,36,38,42,46 The 
number of variables included in the mortality prediction models var-
ied from 5 up to 5695, with a median of 16 (IQR 9-24).
3.2 | Outcome measures
The timing of mortality outcome varied between the stud-
ies. Hospital mortality was the most frequently used 
primary outcome in 29 (67%) mortality prediction mod-
els.6,13-19,21,22,24,27,28,30-33,35,36,38,41-43,45,46 Other primary out-
come variables were ICU mortality (7%),23,26,34 28-day mortality 
(4.7%),39,44 90-day mortality (4.7%),48,49 3- to 28-day mortality 
(4.7%),40 30-day mortality (2.3%),47 180-day mortality (2.3%),20 
6-month mortality (2.3%),25 15-year mortality (2.3%),37 and 6- and 
12-month mortality (2.3%).29
Secondary outcomes were 1-month mortality after ICU admis-
sion (4.7%),24,31 hospital mortality (4.7%),29,34 ICU mortality (2.3%),45 
3-month mortality after ICU admission (2.3%),31 6-month mortality 
after ICU admission (2.3%),31 9-month mortality (2.3%),47 1-year 
mortality (2.3%)45 and length of stay (2.3%).24 Of the 43, 37 mor-
tality prediction models (86%) did not prognosticate any secondary 
outcome.6,13-23,25-28,30,32,33,35-44,46,48,49
Hospital mortality rates of the development cohorts varied from 
6.9% to 48% and were not reported for nine mortality prediction 
models (21%).6,15,18,29,33,40,42
For 21 mortality prediction models (49% of 43), data were 
collected within the first 24 hours after patient admission to the 
ICU.6,13,14,17-19,24,26,27,30,31,34,38,39,42,44,47-49 For 11 prediction models 
(26%), data on ICU admission were collected,16,23,25,28,32,35,36,41,43,45,46 
whereas for the remaining prediction models data timing varied from 
24 days before admission up to 5 days after patient admission to the ICU.
Handling of missing data was not reported in 11 mortal-
ity prediction models (26%),23,25,26,31,33,38,39,41,45,46,49 20 pre-
diction models (47% of 43) excluded records with missing 
data,6,14,16,19,21,24,27,28,30,32,34,40,42-44 six prediction models (14%) 
imputed values with normal or mean values15,17,18,20,22,29 and four 
prediction models (9.3%) reported no missing data.13,35-37 The re-
maining two prediction models (4.7%) excluded patients when more 
than a certain percentage of the data was missing (>5% or >25%).47,48
3.3 | Discrimination, calibration and overall 
performance measures
Discrimination, calibration and overall performance measures are 
presented in Table 2. Of the 43 mortality prediction models, 15 
(35%) were only internally validated,23,26,28-31,33,38-41,44,46,48 13 
(30%) only externally,16,19-21,25,35,36,42,43,47 10 (23%) were both inter-
nally and externally validated,6,13-15,17,18,22,32,34,37 and 5 prediction 
models (12%) were not validated at all.24,27,45,49 In all, 15 prediction 
models (35%) included a description of an external validation in their 
original publication.13,16,20-22,25,34-36,42,43,47
Discrimination was expressed as the AUROC in 42 of the 43 mor-
tality prediction models original publications (98%). Only the APACHE 
II model did not report an AUROC value in the original publication.19 In 
the development cohorts, the lowest discrimination was AUROC 0.72 
(95% CI 0.71-0.74),48 and the highest AUROC 0.91 (95% CI not speci-
fied).30 In the validation cohorts, the lowest AUROC was 0.58 (95% CI 
not specified),44 and the highest AUROC 0.95 (0.91-0.99).23
Calibration measures were expressed by various statistical mea-
sures. The HL goodness-of-fit test was used in 26 mortality prediction 
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models (60%).14-17,21,22,24-26,28,30,32-36,38-41,43,46,48 Calibration plot was 
expressed for 12 prediction models (28%),13,15,20,24,28,30,31,33,35,37,43,48 
and two prediction models (4.7%) presented the calibration slope 
value.30,48 Finally, one prediction model (2.3%) used the likelihood 
ratio test chi-squared value,23 and one prediction model (2.3%) used 
the Quasi likelihood under the Independence Criterion.45 In 11 pre-
diction models (26%), calibration was not assessed.6,18,19,27,29,42,44,47,49
Overall performance was expressed as the Brier score in eight 
mortality prediction models (19%),6,13,28-31,34,41 and as Nagelkerke's 
R2 in two prediction models (4.7%).37,48
4  | DISCUSSION
4.1 | Main findings
In this scoping review, we presented a contemporary overview of 
43 mortality prediction models used in adult ICU patients in high-
income countries. We found varying methodology, and the valida-
tion and performance of individual prediction models differ. Only 
23 mortality prediction models of the 43 (53%) were externally vali-
dated. This overview provides a basis for head-to-head comparison 
of existing mortality prediction models through systematic external 
validation, with the ultimate goal to identify the most suitable pre-
diction model for a certain cohort of patients.
4.2 | Summary of evidence
In previous literature, the maximum number of ICU mortality pre-
diction models reviewed was 12,7 which is considerably less than 
the 43 prediction models identified by this review. Where we in-
cluded all developed prediction models specifically designed to 
assess mortality, other reviews regarding ICU mortality prediction 
models focused mainly on commonly used models like the APACHE, 
SAPS and MPM,3-5 or identified models with different outcome than 
mortality (eg organ dysfunction) or disease- or organ-specific prog-
nostic models.4,5,7,8 Additionally, only Siontis et al and Strand et al 
applied a systematic search to identify the models and discussed 
the validation of the models.5,8 Where we included all developed 
mortality prediction models, Strand et al did only include predic-
tion models when the search for the specific scoring system yielded 
more than 50 citations.5 Siontis et al. conducted an evaluation of 
validated tools for hospitalized patients to predict all-cause mor-
tality. However, their analysis included specific patient groups (eg 
heart or liver patients) rather than general ICU patients as included 
in the current review.8
Model performance is affected by the choice of outcome.31,50 
Most mortality prediction models used hospital mortality as 
outcome measure.6,13-19,21,22,24,27,28,30-33,35,36,38,41-43,45,46 In gen-
eral, longer fixed-time outcome measures used in some mod-
els20,24,25,29,31,37,39,40,44,45,47-49 are currently recommended.51 To 
elaborate, hospital mortality is dependent on discharge practices 
and availability of post-ICU care, and is therefore a subjective 
measure. Furthermore, critical illness affects patients after hos-
pital discharge.
The time span during which the mortality prediction models 
gathered their data varied from short (eg upon ICU admission or 
during the first initial hour of admission to the ICU) to long (eg 
during the first 24 hours of admission). Concerning complexity 
(time consumption) and missing data problems, it may be better 
in some situations to use a simpler model with less missing data 
than a more complex model built from a dataset with more miss-
ing data which achieves a slightly better performance.52 Longer 
collection periods may lead to more complete data, as incomplete-
ness is often substantial for biochemical variables for patients 
with short-duration admissions (ie less than 24 hours). However, 
sampling rate affects predictions.53 This limitation is considered 
less important in models with shorter data collection. Similarly, the 
treatments administered during the first 24 hours in the ICU obvi-
ously also affect predictions.
4.3 | Comparison of performance
We reported the performance of mortality prediction models in 
terms of discrimination, calibration and overall performance values. 
Direct comparison of prediction models predictive performances is 
not possible, as the development cohorts differed substantially from 
one another. As a consequence, prediction models cannot be consid-
ered interchangeable. Comparisons that are not done head-to-head 
in external samples independent of all models developed are at high 
risk of being misleading and may lead to inappropriate conclusions 
and resource use.12
Of 43, 26 (60%) mortality prediction models used the HL good-
ness-of-fit test for calibration.14-17,21,22,24-26,28,30,32-36,38-41,43,46,48 The 
HL test is commonly used, despite being frequently non-significant 
for small data cohorts and nearly always significant for large data co-
horts.54-57 When only the HL test is reported without any calibration 
plot or table comparing predicted and observed outcome frequencies, 
inadequate information regarding calibration is provided.1
Many ICU mortality prediction models are available and compar-
atively assessing their performance is a crucial task.4 In all, 25 articles 
compared the performance of the new model with existing models 
but used the same cohort of patients that was used in the devel-
opment of the ‘novel’ model.6,13,14,16-18,20,22,24,26-30,32,34,40-47,49 This 
methodology is inherently biased in favor of the ‘novel’ model.54,57 
Comparisons between prediction models should therefore only be 
executed in independent external validation samples not used to de-
velop any of the models.
4.4 | Machine-learning algorithms
Mortality prediction models developed as an electronic model or 
derived from a machine-learning algorithm such as AutoTriage58 
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were excluded in our manuscript since code and data availability 
are not requirements in all journals and this is necessary to re-
produce the specific prediction model. However, code availability 
appears to be a rising trend.59 Machine-learning-based prediction 
models seem to achieve increasingly higher accuracies and are be-
coming more dynamic,60 although they still have to include a suf-
ficiently large development and validation cohort to adequately 
assess performance and the risk of overfitting. However, a recent 
systematic review concluded that machine learning did not have 
superior performance over logistic regression for clinical predic-
tion models.61
The association between mortality and variables may have changed 
since the original mortality prediction models were developed, for ex-
ample, as a result of advancements in diagnostics and therapeutics.62 
Mortality alone however is rarely the only outcome measure for inter-
ventional studies in ICU patients, and many trials, especially in sepsis, 
include an organ dysfunction score as part of ongoing patient assess-
ment so that effects on morbidity can also be evaluated.3
Misuse of mortality prediction models can lead to inappropriate 
use of resources and potentially even mismanagement of patient care 
due to incorrect stratification.57 Awareness of the differences in model 
design, the variance of predictions across different ICU settings and 
the effect of heterogeneity in populations are of utmost importance.
4.5 | Limitations
Some limitations of this study need to be addressed. First, having 
restricted our search to the period from 2008, relevant mortal-
ity prediction models might have been overlooked. Even though 
some of the most widely used mortality prediction models pre-
cede the screening period, we identified 16 prediction models 
that were published before 2008, but optimally searches have 
no time limit.63 Second, we only included mortality prediction 
models originally developed for use in the ICU. Mortality predic-
tion models not originally developed for mortality prediction in 
the ICU could still be valuable clinically. Third, in some original 
publications, it was unclear whether the presented discrimination, 
calibration and/or overall performance values were derived from 
the development cohort or from the validation dataset. We aimed 
to clarify these, but certain values might reflect another dataset 
from the original publication. Fourth, we only provided a system-
atic overview of all developed mortality prediction models in adult 
critically ill patients. We did not perform a systematic review of 
every retrieved model complete with all consecutive internal and 
external validations, as results from different external validations 
in different cohorts are not directly comparable due to differences 
in populations, case-mix and settings. We restricted the scope of 
this review to only identify whether internal or external validation 
had been performed as a measure of thoroughness of develop-
ment of the identified models. For this reason, only screening of 
citations of the original articles was done to identify internal and/
or external validation articles. Therefore, we should address that 
our assessment on mortality prediction models not being inter-
nally and/or externally validated might be incomplete if validation 
in different publications was missed. A systematic search spe-
cifically designed for retrieving validation papers is advised when 
systematically reviewing the internal and external validations of 
mortality prediction models.64
4.6 | Unanswered research questions
Although we retrieved many developed mortality prediction mod-
els that can be used as a step towards future head-to-head com-
parison, with the results of this scoping review it is not possible to 
make a recommendation on what mortality prediction models to 
use and it was not our intention to do so. External validation in-
volving direct head-to-head comparisons in independent cohorts 
is needed to unravel the comparable performance of individual 
models. Although we provide a systematic overview of mortal-
ity prediction models and describe whether these were internally 
and/or externally validated, it was not desirable to give an over-
view of all external validations of the prediction models since this 
would require a specific search strategy for each model. Moreover, 
we would have liked to assess risk of bias using the recently devel-
oped PROBAST score.1 However, this was not feasible because of 
the number of prediction models.
5  | FUTURE PERSPEC TIVES
To identify the most suitable mortality prediction model for a cer-
tain patient cohort, ideally a head-to-head comparison of available 
models should be performed through systematic external validation 
using prospectively obtained datasets and appropriate statistical 
methods. The eventual aim will be to use this review to identify, up-
date and implement the best performing mortality prediction mod-
els in daily practice. We are in the process of validating the found 
prediction models in independent contemporary cohorts to provide 
external validation of these models. Second, the process should be 
performed in different cohorts as heterogeneity of ICU patients ex-
ists on multiple levels, that is, patient level, hospital level, region and 
country level.65 The best mortality prediction model in one setting 
is not necessarily the best performing prediction model in another 
setting. Third, it is worth mentioning that ICU patients have reduced 
long-term survival and impaired quality of life after ICU discharge 
compared to the general population.66 Future research should also 
look at determinants of poor outcomes in ICU survivors to help 
guide long-term follow-up.67
6  | CONCLUSIONS
In this review, 43 mortality prediction models have been studied. 
The validation and performance of individual prediction models 
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differ and the best prediction models for guiding clinical care and 
research is still to be established.
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